Late onset pityriasis rubra pilaris type IV treated with low-dose acitretin

被引:3
作者
Mota, Fernando [1 ]
Carvalho, Sandrina [1 ]
Sanches, Madalena [1 ]
Selores, Manuela [1 ,2 ,3 ]
机构
[1] Porto Cent Hosp, Dept Dermatol, Oporto, Portugal
[2] Porto Cent Hosp, Dermatol Res Unit, Oporto, Portugal
[3] Univ Porto, Abel Salazar Biomed Sci Inst, Oporto, Portugal
来源
ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA | 2016年 / 25卷 / 01期
关键词
Pityriasis rubra pilaris; treatment; acitretin;
D O I
10.15570/actaapa.2016.4
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Pityriasis rubra pilaris is a chronic inflammatory dermatosis of unknown etiology and great clinical variability. It has been divided into six categories. Types III, IV, and V occur in childhood and are distinguished by their clinical presentation, age of onset, and course. We report a 19-year-old male patient with a 2-week history of pruritic, scaling dermatosis of the hands, feet, elbows, and knees. He had no family history of skin disease. On physical examination, we observed circumscribed, reddish-orange, scaling plaques affecting the elbows and knees and a waxy palmoplantar keratoderma. The skin biopsy showed acanthosis, alternating orthokeratosis, parakeratosis, and follicular plugging suggestive of pityriasis rubra pilaris. The patient started treatment with oral acitretin, 25 mg every other day. The treatment was tolerated well, and after 6 months the lesions had resolved completely. Pityriasis rubra pilaris is a chronic papulosquamous disorder of unknown pathogenesis, characterized by reddish-orange scaly plaques, palmoplantar keratoderma, and keratotic follicular papules. There is still no consensus regarding the treatment, but therapeutic options include systemic retinoids, particularly acitretin in the recommended dose of 0.5 to 0.75 mg/kg/day. In our case, the patient was treated with a low-dose regimen of acitretin, which was effective and well tolerated.
引用
收藏
页码:15 / 17
页数:3
相关论文
共 9 条
[1]  
Bragg Jennifer, 2005, Dermatol Online J, V11, P14
[2]   TREATMENT OF CLASSIC PITYRIASIS-RUBRA-PILARIS [J].
DICKEN, CH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 31 (06) :997-999
[3]  
Goldsmith LA, 2012, FITZPATRICKS DERMATO, P279
[4]  
Gomez Minerva, 2007, J Drugs Dermatol, V6, P337
[5]   PITYRIASIS RUBRA PILARIS [J].
GRIFFITHS, WAD .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1980, 5 (01) :105-112
[6]   Pityriasis Rubra Pilaris A Review of Diagnosis and Treatment [J].
Klein, Annette ;
Landthaler, Michael ;
Karrer, Sigrid .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2010, 11 (03) :157-170
[7]   Acitretin in dermatology [J].
Sarkar, Rashmi ;
Chugh, Shikha ;
Garg, Vijay K. .
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2013, 79 (06) :759-771
[8]   HISTOLOGIC CRITERIA FOR THE DIAGNOSIS OF PITYRIASIS-RUBRA-PILARIS [J].
SOEPRONO, FF .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1986, 8 (04) :277-283
[9]   Juvenile pityriasis rubra pilaris: Report of 28 cases in Taiwan [J].
Yang, Chao-Chun ;
Shih, I-Shin ;
Lin, Wan-Lung ;
Yu, Yi-Sheng ;
Chiu, Hsien-Ching ;
Huang, Po-Han ;
Cheng, Yu-Wen ;
Lee, Julia Yu-Yun ;
Chen, WenChieh .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 59 (06) :943-948